Skip navigation

 Login or Register | Member Centre

GlobeInvestorGOLD Canada's most comprehensive investment tool.

 
Change Symbol: Lookup Trade Now

Endo Pharmaceuticals Hldgs | Headlines

  • Vol:
  • Last Trade:
Search found 37 documents NextNext
1: Endo Pharmaceuticals Announces Receipt of Paragraph IV Certification
PR NEWSWIRE, January 19, 2010 08:00 AM

2: Endo Pharmaceuticals and LecTec Settle Patent Dispute
PR NEWSWIRE, November 11, 2009 04:13 PM

3: Endo Pharmaceuticals Reports Third Quarter 2009 Financial Results and Increases Full-Year Financial Guidance
PR NEWSWIRE, October 29, 2009 07:15 AM

4: Endo Pharmaceuticals Gives Update on Regulatory Status of FORTESTA(TM)
PR NEWSWIRE, October 19, 2009 08:30 AM

5: Endo Pharmaceuticals to Announce Third Quarter 2009 Financial Results on October 29, 2009
PR NEWSWIRE, October 8, 2009 09:03 AM

6: Endo Pharmaceuticals Announces Expiration of Cash Tender Offer for Ledgemont PhaRMA(SM) Secured 16% Notes
PR NEWSWIRE, September 25, 2009 09:02 AM

7: Endo Pharmaceuticals Introduces VALSTAR(TM) (Valrubicin) To Fill Unmet Need In Aggressive Form of Bladder Cancer
PR NEWSWIRE, September 3, 2009 08:30 AM

8: Endo Pharmaceuticals Gives Update on Regulatory Status of Testosterone Undecanoate for Men with Hypogonadism
PR NEWSWIRE, September 2, 2009 04:05 PM

9: Endo Pharmaceuticals to Present at Thomas Weisel Partners Healthcare Conference 2009
PR NEWSWIRE, August 31, 2009 04:59 PM

10: Endo Pharmaceuticals to Partner With ProStrakan to Commercialize FORTESTA(TM) in the U.S.
PR NEWSWIRE, August 26, 2009 08:50 AM

NextNext
 

Search using one or more of the following options:

Symbol Lookup
 
 
  Search Tips
 
  * Can only be used when searching The Globe and Mail and newswires.

Back to top